CA2142872A1 - Methodes de surveillance de l'efficacite du traitement a l'interferon chez des patients infectes par le vhc - Google Patents

Methodes de surveillance de l'efficacite du traitement a l'interferon chez des patients infectes par le vhc

Info

Publication number
CA2142872A1
CA2142872A1 CA 2142872 CA2142872A CA2142872A1 CA 2142872 A1 CA2142872 A1 CA 2142872A1 CA 2142872 CA2142872 CA 2142872 CA 2142872 A CA2142872 A CA 2142872A CA 2142872 A1 CA2142872 A1 CA 2142872A1
Authority
CA
Canada
Prior art keywords
hcv
gor
igm
igg
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2142872
Other languages
English (en)
Inventor
Lieselotte Lennartz
Gerd Michel
Smriti U. Mehta
Suhas Taskar
John M. Clemens
Larry T. Mimms
Kurt H. Chau
David S. Vallari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2142872A1 publication Critical patent/CA2142872A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA 2142872 1992-08-21 1993-08-03 Methodes de surveillance de l'efficacite du traitement a l'interferon chez des patients infectes par le vhc Abandoned CA2142872A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93328392A 1992-08-21 1992-08-21
US07/933,283 1992-08-21

Publications (1)

Publication Number Publication Date
CA2142872A1 true CA2142872A1 (fr) 1994-03-03

Family

ID=25463683

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2142872 Abandoned CA2142872A1 (fr) 1992-08-21 1993-08-03 Methodes de surveillance de l'efficacite du traitement a l'interferon chez des patients infectes par le vhc

Country Status (5)

Country Link
EP (1) EP0656116A4 (fr)
JP (1) JPH08500673A (fr)
AU (1) AU4996493A (fr)
CA (1) CA2142872A1 (fr)
WO (1) WO1994004922A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447650A (en) * 1993-10-06 1995-09-05 Allergan, Inc. Composition for preventing the accumulation of inorganic deposits on contact lenses
EP0848821B1 (fr) * 1995-06-07 1999-10-27 Abbott Laboratories RAPPORT IgG/IgM POUR DETERMINER L'EFFICACITE DE LA THERAPIE PAR INTERFERONS CHEZ DES INDIVIDUS ATTEINTS D'INFECTIONS VHC
CA2549865A1 (fr) * 2003-11-12 2005-06-02 Hbv Theranostica Ab Procedes et moyens associes a l'infection par le virus de l'hepatite b
GB0326416D0 (en) 2003-11-12 2003-12-17 Karolinska Innovations Ab Methods and means relating to hepatitis B infection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide

Also Published As

Publication number Publication date
EP0656116A1 (fr) 1995-06-07
WO1994004922A1 (fr) 1994-03-03
JPH08500673A (ja) 1996-01-23
AU4996493A (en) 1994-03-15
EP0656116A4 (fr) 1997-04-02

Similar Documents

Publication Publication Date Title
RU2130969C1 (ru) Композиция для диагностики гепатита c человека (варианты), способ и набор для обнаружения антител к вирусу гепатита c человека
EP0651253A1 (fr) Essai immunologique pour la detéction des autoanticorps humaines
JP3715027B2 (ja) Ｃ型肝炎ウイルス感染症診断薬
CA3181751A1 (fr) Detection d'anticorps contre le sars-cov-2
US20090280474A1 (en) Method for detecting a virus
CA2142872A1 (fr) Methodes de surveillance de l'efficacite du traitement a l'interferon chez des patients infectes par le vhc
WO1993020445A1 (fr) IMMUNOANALYSE PERMETTANT LA DETECTION DE L'ANTICORPS IgM DE HCV
WO2009036227A1 (fr) Détection du virus de l'hépatite b
AU664179B2 (en) Immunoassay for detecting HCV IgM antibody
Franco et al. Evaluation of an enzyme-linked immunosorbent assay for quantitation of antibodies to Junin virus in human sera
EP0848821B1 (fr) RAPPORT IgG/IgM POUR DETERMINER L'EFFICACITE DE LA THERAPIE PAR INTERFERONS CHEZ DES INDIVIDUS ATTEINTS D'INFECTIONS VHC
AU5689500A (en) Assay
US8076085B2 (en) Methods and means relating to hepatitis B infection
WO2011068720A1 (fr) Détection de mutants du virus de l'hépatite b
AU2004290800B2 (en) Methods and means relating to hepatitis B infection
US20030032031A1 (en) Use of specific antibody titers to predict hepatic failure in people infected with hepatitis C virus
JP4005093B2 (ja) Ｃ型肝炎ウイルス感染症診断薬および抗ｈｃｖ抗体検出方法
Ushijima et al. Development of a simple and rapid latex test for rotavirus in stool samples.
RU2084527C1 (ru) Набор для определения антител к вирусу гепатита c человека (варианты)
JPH11507129A (ja) Ｃ型肝炎ウイルス第二エンベロープ糖タンパク質に対する抗体の検出法

Legal Events

Date Code Title Description
FZDE Dead